Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-10 4:16 pm Purchase |
2023-06-28 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Venrock Healthcare Capital Partners III L.P. | 319,200 9.990% |
319,200 (New Position) |
Filing |